» Articles » PMID: 9385632

Crystal Structure of Cyclophilin A Complexed with a Binding Site Peptide from the HIV-1 Capsid Protein

Overview
Journal Protein Sci
Specialty Biochemistry
Date 1998 Feb 12
PMID 9385632
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The cellular protein, cyclophilin A (CypA), is incorporated into the virion of the type 1 human immunodeficiency virus (HIV-1) via a direct interaction with the capsid domain of the viral Gag polyprotein. We demonstrate that the capsid sequence 87His-Ala-Gly-Pro-Ile-Ala92 (87HAGPIA92) encompasses the primary cyclophilin A binding site and present an X-ray crystal structure of the CypA/HAGPIA complex. In contrast to the cis prolines observed in all previously reported structures of CypA complexed with model peptides, the proline in this peptide, Pro 90, binds the cyclophilin A active site in a trans conformation. We also report the crystal structure of a complex between CypA and the hexapeptide HVGPIA, which also maintains the trans conformation. Comparison with the recently determined structures of CypA in complexes with larger fragments of the HIV-1 capsid protein demonstrates that CypA recognition of these hexapeptides involves contacts with peptide residues Ala(Val) 88, Gly 89, and Pro 90, and is independent of the context of longer sequences.

Citing Articles

HIV-1 capsid and viral DNA integration.

Dwivedi R, Prakash P, Kumbhar B, Balasubramaniam M, Dash C mBio. 2023; 15(1):e0021222.

PMID: 38085100 PMC: 10790781. DOI: 10.1128/mbio.00212-22.


Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus.

Padron A, Prakash P, Pandhare J, Luban J, Aiken C, Balasubramaniam M J Virol. 2023; 97(11):e0073223.

PMID: 37843371 PMC: 10688351. DOI: 10.1128/jvi.00732-23.


The type III secretion chaperone SctY may shield the hydrophobic export gate-binding C-terminus of its substrate SctX.

Gilzer D, Kowal J, Flottmann F, Niemann H Acta Crystallogr D Struct Biol. 2023; 79(Pt 6):508-517.

PMID: 37204817 PMC: 10233624. DOI: 10.1107/S2059798323003248.


Clade-Specific Alterations within the HIV-1 Capsid Protein with Implications for Nuclear Translocation.

Dick A, Meuser M, Cocklin S Biomolecules. 2022; 12(5).

PMID: 35625621 PMC: 9138599. DOI: 10.3390/biom12050695.


Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents.

Han J, Lee M, Jang Y, Cho W, Kim M Drug Discov Today. 2022; 27(7):1895-1912.

PMID: 35609743 PMC: 9123807. DOI: 10.1016/j.drudis.2022.05.016.


References
1.
Studier F, Moffatt B . Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986; 189(1):113-30. DOI: 10.1016/0022-2836(86)90385-2. View

2.
Steinkasserer A, Harrison R, Billich A, Hammerschmid F, Werner G, Wolff B . Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication. J Virol. 1995; 69(2):814-24. PMC: 188647. DOI: 10.1128/JVI.69.2.814-824.1995. View

3.
Colley N, Baker E, Stamnes M, Zuker C . The cyclophilin homolog ninaA is required in the secretory pathway. Cell. 1991; 67(2):255-63. DOI: 10.1016/0092-8674(91)90177-z. View

4.
Xu Q, Leiva M, Fischkoff S, Handschumacher R, Lyttle C . Leukocyte chemotactic activity of cyclophilin. J Biol Chem. 1992; 267(17):11968-71. View

5.
Freskgard P, Bergenhem N, Jonsson B, Svensson M, Carlsson U . Isomerase and chaperone activity of prolyl isomerase in the folding of carbonic anhydrase. Science. 1992; 258(5081):466-8. DOI: 10.1126/science.1357751. View